A detection material for MOG-IgG autoantibody based on CBA method and its preparation method and application
By converting MOGα1 and MOG10 genes in the CBA method, cell crawlers that can be overexpressed simultaneously were prepared, which solved the problems of short shelf life and low sensitivity of the detection materials, and achieved more efficient and more accurate detection of MOG-IgG antibody.
Patent Information
- Application Number
- CN202210969678.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-08-12
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-08-12
AI Technical Summary
The existing CBA method detects that MOG-IgG antibodies have problems with short shelf life, low sensitivity and non-specific staining.
Using the MOG-IgG autoantibodies detection material based on the CBA method, cell crawlers that can simultaneously overexpress MOGα1 and MOG10 are prepared by co-transferring the recombinant vectors of MOGα1 and MOG10 genes to cells to be prepared for detection of MOG-IgG antibodies and prolonging them. The shelf life of the crawler film is improved, the detection sensitivity is improved, and the specificity of the positive signal is enhanced.
It extends the shelf life of the detection material, improves the detection sensitivity, enhances the specificity of the positive signal, reduces false positives and false negatives, improves the detection accuracy of MOG-IgG samples, and helps in the diagnosis and treatment of diseases.
Smart Images

Figure CN115343464B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of antibody detection, and in particular relates to a detection material for MOG-IgG autoantibodies based on a CBA method, a preparation method and an application thereof. Background Art
[0002] Myelin oligodendrocyte glycoprotein (MOG) is a myelin glycoprotein specifically expressed on oligodendrocytes in the central nervous system (CNS) and localized in the outermost layer of the CNS myelin sheath. Due to this localization, it becomes a major target antigen involved in immune-mediated demyelination and may be involved in the integrity and maintenance of the myelin sheath and intercellular communication. In addition, splicing transcript variants encoding different isoforms have also been identified, including alpha1, alpha2, alpha3, alpha5, alpha6, beta1, beta2, beta3, beta5, and 10. Among them, the MOG isoforms with the strongest IgG reaction are alpha1 (abbreviated as MOGα1, currently used for the standard detection of MOG-IgG) and beta1, while other isoforms are less frequently recognized; the newly discovered transcript variant 10 represents the longest transcript and translates the longest isoform MOG10.
[0003] According to the 2018 MOG encephalitis international expert consensus study, MOG-IgG has a direct pathogenic effect. MOG-IgG is now considered a disease in itself, different from classic MS and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD), and is now commonly referred to as MOG-IgG-associated encephalomyelitis (MOG-EM). The expert consensus made detailed recommendations for the detection of MOG-IgG antibodies and the diagnosis of MOG-EM, and used the full-length human MOG protein as the target antigen and the MOG-IgG serum positivity detected by the cell-based assay (CBA) as one of the diagnostic criteria for MOG encephalitis.
[0004] Currently, the CBA method is also the gold standard for detecting MOG-IgG, but the use of the CBA method to detect antibodies still has defects such as limited product shelf life, low sensitivity, and non-specific staining. Summary of the invention
[0005] In order to overcome the shortcomings of the above-mentioned prior art, the purpose of the present invention is to provide a detection material for MOG-IgG autoantibodies based on the CBA method, and a preparation method and application thereof, which can effectively solve the technical problems of short shelf life, low sensitivity and nonspecific staining in the detection of MOG-IgG in the prior art.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] The invention discloses a detection material for MOG-IgG autoantibodies based on a CBA method, wherein the detection material is a detection material capable of simultaneously overexpressing MOGα1 and MOG10.
[0008] Preferably, the detection material is obtained by co-transfecting the recombinant vector of the MOGα1 gene and the recombinant vector of the MOG10 gene into cells.
[0009] Preferably, the sequence number of the MOGα1 gene is NM_206809.4.
[0010] More preferably, the recombinant vector of the MOGα1 gene is PCDNA3.1-MOGα1, or 17T2A-MOGα1.
[0011] Preferably, the sequence number of the MOG10 gene is NM_001363610.2.
[0012] Preferably, the recombinant vector of the MOG10 gene is PCDNA3.1-MOG10, or may be 17T2A-MOG10.
[0013] More preferably, the cells are HEK293T cells.
[0014] Preferably, the total mass of the PCDNA3.1-MOGα1 and PCDNA3.1-MOG10 when co-transfected can be 2-10 ug, and the mass ratio of the total mass of the recombinant vector to the mass of PEI is ≤1;
[0015] More preferably, the mass ratio of PCDNA3.1-MOGα1 and PCDNA3.1-MOG10 during co-transfection is 1:(1-3).
[0016] Further preferably, the detection material is a cell slide.
[0017] The invention discloses a preparation method of a detection material for MOG-IgG autoantibodies based on a CBA method. The method is an indirect immunofluorescence method of transfected cells, wherein a recombinant vector of a MOGα1 gene and a recombinant vector of a MOG10 gene are co-transfected into cells to obtain cells that simultaneously overexpress MOGα1 and MOG10, the transfected cells are fixed and then washed, an antigen repair solution is added for termination treatment, and the washed slide is dried and stored, so as to obtain a cell slide (named MOGα1+10) for detecting MOG-IgG autoantibodies.
[0018] The above-mentioned addition of antigen repair solution for termination treatment can refer to the antigen repair solution disclosed in Chinese patent CN202111021983.3, the cell slide prepared using the same, and the preparation method and application of the cell slide, and the operation and treatment can be performed according to the method therein.
[0019] Preferably, the cells used for transfection are HEK293T cells.
[0020] Preferably, during the preparation process, the cell culture dish can be a dish or well plate of any specification suitable for cell culture; the climbing slide is a sterile climbing slide of any size treated with poly-lysine.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] The present invention co-transfects a subtype MOGα1 recombinant vector used for standard detection of MOG-IgG with a longest subtype MOG10 recombinant vector to obtain a cell slide (named MOGα1+10) capable of simultaneously overexpressing MOGα1 and MOG10 for detecting MOG-IgG by CBA method, thereby extending the shelf life of the slide and improving the detection sensitivity. At the same time, the specific fluorescent staining morphology of the positive signal in some MOG-IgG samples is easier to distinguish from nonspecific staining. These characteristics are helpful for the detection of MOG-IgG in clinical samples and the diagnosis, treatment and prognosis of corresponding diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is a staining result diagram for verifying the shelf life of the MOGα1+10 cell slide prepared in Example 1 of the present invention;
[0024] Figure 2 This is a staining result diagram for verifying the shelf life of the MOGα1 cell slide prepared in Comparative Example 1;
[0025] Figure 3 This is a staining result diagram for verifying the shelf life of the MOG10 cell slide prepared in Comparative Example 2;
[0026] Figure 4This is a staining result diagram for verifying the shelf life of the MOG10MOG10 cell slide prepared in Comparative Example 3;
[0027] Figure 5 The staining results of comparing the detection sensitivity of positive samples using MOGα1+10, MOGα1, MOG10, and MOG10MOG10 cell slides respectively;
[0028] Figure 6 These are the staining results of the specific fluorescent staining morphology of positive samples detected using MOGα1+10, MOGα1, MOG10, and MOG10MOG10 cell slides. DETAILED DESCRIPTION
[0029] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.
[0030] It should be noted that the terms "first", "second", etc. in the specification and claims of the present invention and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the present invention described herein can be implemented in an order other than those illustrated or described herein. In addition, the terms "including" and "having" and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.
[0031] The present invention is further described in detail below in conjunction with the accompanying drawings:
[0032] The present invention provides a method for detecting MOG-IgG autoantibodies by CBA method. PCDNA3.1-MOGα1 recombinant vector and PCDNA3.1-MOG10 recombinant vector are co-transfected into 293T cells to obtain cell slides simultaneously overexpressing MOGα1 and MOG10. Compared with cell slides overexpressing MOGα1 or MOG10 alone, the shelf life is significantly prolonged. Further research shows that when detecting MOG-IgG antibodies, the sensitivity is improved to a certain extent, the characteristic of positive signal specific staining is more prominent, which is conducive to the judgment of the results and can reduce the occurrence of false positives and false negatives to a certain extent.
[0033] The steps for preparing MOGα1+10 cell slides disclosed in the present invention are as follows:
[0034] Step 1: Take a slide of appropriate size that has been treated with acid and alkali and sterilized, and then soaked in poly-lysine and place it in a cell culture dish;
[0035] Step 2: After trypsin digestion, resuspend the cells in DMEM-FBS high-glucose complete medium, and spread the resuspended cell suspension on the cell culture dish treated in step 1;
[0036] Step 3: When the cells grow to 30%-40%, the recombinant vector is transferred by transient transfection, that is, PCDNA3.1-MOGα1 and PCDNA3.1-MOG10 are added to DMEM high-glucose basal medium in sequence according to the mass ratio, and then a certain amount of transfection reagent polyethyleneimine (PEI) is added. After the cells are still, the slides with cells laid in step 2 are added, and after 4-6 hours, the medium is replaced with DMEM-FBS high-glucose complete medium;
[0037] Step 4: After the cells have grown for 24 to 72 hours, the grown cell slides are fixed with formaldehyde solution, paraformaldehyde solution or glutaraldehyde solution, washed and terminated with antigen repair solution, dried and stored to obtain MOGα1+10 cell slides.
[0038] Preferably, the above step 3 can also be that the plasmids PCDNA3.1-MOGα1 and PCDNA3.1-MOG10 are first added to the DMEM high-glucose basal culture medium according to the mass ratio, and then a certain amount of PEI is added respectively. After mixing and standing, they are added together to the culture dish with the cell slides in the above step 2, and replaced with DMEM-FBS high-glucose complete culture medium after 4-6 hours.
[0039] Further preferably, the DMEM-FBS high-glucose complete medium is prepared by adding 10%-15% FBS to DMEM high-glucose basal medium.
[0040] Preferably, the step of making MOGα1+10 cell slides can also be to revive the stable cell line obtained by stable transfection, spread it on the slide, and when the cell density grows to ≥80%, fix the grown cell slides with formaldehyde solution, paraformaldehyde solution or glutaraldehyde solution, wash and terminate the treatment with antigen repair solution, dry and store, so as to obtain MOGα1+10 cell slides.
[0041] The specific steps of the above-mentioned cell slide quality inspection method are as follows:
[0042] 1) Take a MOGα1+10 cell slide and soak it in PBST for ten minutes;
[0043] 2) Primary antibody incubation: incubate known MOG-IgG positive samples and known MOG-IgG negative samples separately for 1 hour;
[0044] 3) Washing: Wash 3 times with PBST, 5 min each time;
[0045] 4) Secondary antibody incubation: Secondary antibody incubation time 30min;
[0046] 5) Washing: Wash 3 times with PBST, 5 min each time;
[0047] 6) Observation results: Observe the results under a fluorescence microscope.
[0048] 7) Interpretation of results: If the titer of the positive sample is consistent with the known titer, and there is no false positive in the negative test, the slide quality inspection is qualified; otherwise, the slide quality inspection is unqualified.
[0049] Preferably, when judging MOG-IgG to be positive, the fluorescent signal is clear, generally located on the cell membrane, with an irregular shape, and stronger than the surrounding cell background coloring; part of the positive signal can be distributed on the cell protrusions, showing a relatively complete cell morphology.
[0050] Further preferably, when judging MOG-IgG positivity, it is necessary to distinguish between specific positive signals and nonspecific staining. Some cells have suspected positive signals due to nonspecific membrane localization staining, which is slightly stronger than the background. The corresponding cell morphology is observed under bright field. If it is a circle with clear edges or a nearly circle, and the color is slightly darker than normal cells, it is nonspecific staining.
[0051] Example 1 Preparation of MOGα1+10 cell slides and verification of their effects
[0052] 1. Preparation of MOGα1+10 cell slides
[0053] 1. Construction of plasmid
[0054] (1) The gene sequence of MOGα1 was obtained from the GenBank sequence database, with the reference sequence number NM_206809.4, and the gene was synthesized into the PCDNA3.1 vector, with the selected restriction sites being SalⅠ and NotⅠ, and the gene was recorded as PCDNA3.1-MOGα1; the gene sequence of MOG10 was obtained, with the reference sequence number NM_001363610.2, and the gene was synthesized into the PCDNA3.1 vector, with the selected restriction sites being SalⅠ and NotⅠ, and the gene was recorded as PCDNA3.1-MOG10;
[0055] (2) Extract the constructed recombinant vectors PCDNA3.1-MOGα1 and PCDNA3.1-MOG10 and set them aside.
[0056] 2. Production
[0057] (1) Cell culture
[0058] Prepare DMEM-FBS high-glucose complete medium containing 10%-15% FBS. When the cell confluence is about 90%-100%, subculture the cells at a ratio of 1:5-1:6 to a culture dish with slides laid on it, and culture them overnight in a cell culture incubator at 37°C and 5% CO2.
[0059] (2) Plasmid transfection
[0060] When the cells grew to 30%-40%, 4 μg of PCDNA3.1-MOGα1 plasmid and 5 μg of PCDNA3.1-MOG10 plasmid were taken and added to DMEM high-glucose basal medium in sequence, and then 10 μg of PEI was added, and transfection was performed according to the PEI transfection method. After 4-6 hours of transfection, the medium was replaced with DMEM-FBS high-glucose complete medium containing 10%-15% FBS, and cultured overnight in a cell culture incubator at 37°C and 5% CO2;
[0061] (3) Cell fixation
[0062] After about 24 to 72 hours, when the cells grow to a confluence of ≥90%, the grown cell slides are fixed with formaldehyde solution, paraformaldehyde solution or glutaraldehyde solution, washed with phosphate buffer, terminated with antigen repair solution, dried and stored to obtain MOGα1+10 cell slides.
[0063] 2. Experimental verification of the effect of MOGα1+10 cell climbing
[0064] 1. Verification of the shelf life of MOGα1+10 cell slides
[0065] The MOGα1+10 cell slides prepared above were placed at different temperatures, namely 37°C, 4°C and -20°C, and the slides were taken out regularly to verify the positive signal.
[0066] Experimental steps:
[0067] 1) Take the MOGα1+10 cell slide prepared above and soak it in PBST for ten minutes;
[0068] 2) Primary antibody incubation: incubate positive samples for 1 hour;
[0069] 3) Washing: Wash 3 times with PBST, 5 min each time;
[0070] 4) Secondary antibody incubation: Secondary antibody incubation time 30 min;
[0071] 5) Washing: Wash 3 times with PBST, 5 min each time;
[0072] 6) Observation results: Observe the results under a fluorescence microscope.
[0073] Experimental results: MOGα1+10 cell slides were placed at different temperatures, and the staining results of positive signals were verified regularly. The positive signal can be kept at 37℃ for at least 60 days without any change; the positive signal can be kept at 4℃ for at least 365 days without any change; and the positive signal can be kept at -20℃ for at least 365 days without any change. The specific staining results are as follows: Figure 1 shown.
[0074] 2. Verification of the detection sensitivity of MOGα1+10 cell slides
[0075] The MOGα1+10 cell slides prepared in this example were used to detect 30 MOG-IgG positive samples.
[0076] Experimental steps:
[0077] 1) Take a MOGα1+10 cell slide and soak it in PBST for ten minutes;
[0078] 2) Primary antibody incubation: incubate positive samples for 1 hour;
[0079] 3) Washing: Wash 3 times with PBST, 5 min each time;
[0080] 4) Secondary antibody incubation: Secondary antibody incubation time 30 min;
[0081] 5) Washing: Wash 3 times with PBST, 5 min each time;
[0082] 6) Observation results: Observe the results under a fluorescence microscope.
[0083] Experimental results: All 30 MOG-IgG positive samples were detected.
[0084] Comparative Example 1 Preparation of MOGα1 cell slides and verification of their effects
[0085] 1. Preparation of MOGα1 cell slides
[0086] 1. Construction of plasmid
[0087] Take the plasmid PCDNA3.1-MOGα1 constructed in Example 1 and set it aside.
[0088] 2. Production
[0089] (1) Cell culture: Same as Example 1
[0090] (2) Plasmid transfection
[0091] When the cells grow to 30%-40%, take 9 μg of PCDNA3.1-MOGα1 plasmid and add it to DMEM high-glucose basal medium, then add 10 μg PEI, and perform transfection according to the PEI transfection method. After 4-6 hours of transfection, change to DMEM-FBS high-glucose complete medium containing 10-15% FBS, and culture overnight in a cell culture incubator at 37°C and 5% CO2;
[0092] (3) Cell fixation: Same as Example 1; dried and stored to obtain MOGα1 cell slides.
[0093] 2. Experimental verification of the effect of MOGα1 cell climbing
[0094] 1. Verification of the shelf life of MOGα1 cell slides
[0095] Experimental steps: The experimental operation steps are the same as those for verifying the shelf life of MOGα1+10 cell slides in Example 1 above.
[0096] Experimental results: MOGα1 cell slides were placed at different temperatures, and the staining results of positive signals were verified regularly. The positive signal can be kept at 37℃ for at least 21 days without any change; the positive signal can be kept at 4℃ for at least 180 days without any change; and the positive signal can be kept at -20℃ for at least 180 days without any change; the specific staining results are as follows: Figure 2 shown.
[0097] 2. Verification of the detection sensitivity of MOGα1 cell slides
[0098] The experimental operation steps are the same as those for verifying the detection sensitivity of MOGα1+10 cell slides in Example 1 above.
[0099] Experimental results: Among the 30 MOG-IgG positive samples, 29 were positive and 1 was negative.
[0100] Comparative Example 2 Preparation of MOG10 cell slides and verification of their effects
[0101] 1. Preparation of MOG10 cell slides
[0102] 1. Construction of plasmid
[0103] Take the plasmid PCDNA3.1-MOG10 constructed in Example 1 and set it aside.
[0104] 2. Production
[0105] (1) Cell culture: Same as Example 1
[0106] (2) Plasmid transfection
[0107] When the cells grow to 30%-40%, take 9 μg of PCDNA3.1-MOG10 plasmid and add it to DMEM high-glucose basal medium, then add 10 μg PEI, and perform transfection according to the PEI transfection method. After 4-6 hours of transfection, change to DMEM-FBS high-glucose complete medium containing 10%-15% FBS, and culture overnight in a cell culture incubator at 37°C and 5% CO2;
[0108] (3) Cell fixation: Same as Example 1; dried and stored to obtain MOG10 cell slides.
[0109] 2. Experimental verification of the effect of MOG10 cell climbing
[0110] 1. Verification of the shelf life of MOG10 cell slides
[0111] Experimental steps: The experimental operation steps are the same as those for verifying the shelf life of MOGα1+10 cell slides in Example 1 above.
[0112] Experimental results: MOG10 cell slides were placed at different temperatures, and the staining results of positive signals were verified regularly. The positive signal can be kept at 37℃ for at least 30 days without any change; the positive signal can be kept at 4℃ for at least 180 days without any change; and the positive signal can be kept at -20℃ for at least 180 days without any change. The specific staining results are as follows: Figure 3 shown.
[0113] 2. Verification of detection sensitivity of MOG10 cell slides
[0114] The experimental operation steps are the same as those for verifying the detection sensitivity of MOGα1+10 cell slides in Example 1 above.
[0115] Experimental results: Among the 30 MOG-IgG positive samples, 28 were positive and 2 were negative.
[0116] Comparative Example 3 Preparation of MOG10MOG10 cell slides and verification of their effects
[0117] 1. Preparation of MOG10MOG10 cell slides
[0118] 1. Construction of plasmid
[0119] (1) The MOG10 gene without the stop codon was inserted into the PCDNA3.1-MOG10 constructed in Example 1, with the insertion sites being NheⅠ and SalⅠ, and recorded as PCDNA3.1-MOG10MOG10;
[0120] (2) Extract the constructed recombinant vector PCDNA3.1-MOG10MOG10 and set aside.
[0121] 2. Production
[0122] (1) 293T cell culture: the same as in Example 1;
[0123] (2) Plasmid transfection
[0124] When the cells grow to 30%-40%, take 9 μg of PCDNA3.1-MOG10MOG10 plasmid and add it to DMEM high-glucose basal medium, then add 10 μg PEI, and perform transfection according to the PEI transfection method. After 4-6 hours of transfection, change to DMEM-FBS high-glucose complete medium containing 10%-15% FBS, and culture overnight in a cell culture incubator at 37°C and 5% CO2;
[0125] (3) Cell fixation: Same as Example 1, the cells were dried and stored to obtain MOG10MOG10 cell slides.
[0126] 2. Verification of the effect of MOG10MOG10 cell slide
[0127] 1. MOG10MOG10 cell slide shelf life verification
[0128] Experimental steps: The experimental operation steps are the same as those for verifying the shelf life of MOGα1+10 cell slides in Example 1 above.
[0129] Experimental results: MOG10MOG10 cell slides were placed at different temperatures, and the staining results of positive signals were verified regularly. The positive signal can be kept at 37℃ for at least 30 days without any change; the positive signal can be kept at 4℃ for at least 180 days without any change; and the positive signal can be kept at -20℃ for at least 180 days without any change. The specific staining results are as follows: Figure 4 shown.
[0130] 2. Verification of the detection sensitivity of MOG10MOG10 cell slides
[0131] The experimental operation steps are the same as those for verifying the detection sensitivity of MOGα1+10 cell slides in Example 1 above.
[0132] Experimental results: Among the 30 MOG-IgG positive samples, 28 were positive and 2 were negative.
[0133] Summary of experimental results:
[0134] Experimental conclusion 1
[0135] From the experimental results of the above embodiments and comparative examples, it can be seen that the positive signal of MOGα1+10, MOGα1, MOG10, and MOG10MOG10 cell slides stored at different temperatures will become weaker and weaker until there is no positive signal over time, and the higher the temperature, the shorter the duration of the positive signal. Compared with the single-transformed MOGα1, MOG10, and MOG10MOG10, the co-transformed MOGα1+10 slide has a significantly longer duration of positive signals and a significantly longer shelf life. The results are shown in Table 1 below:
[0136] Table 1
[0137]
[0138] Experimental conclusion 2
[0139] From the experimental results of the above embodiments and comparative examples, it can be seen that 30 MOG-IgG positive samples were detected using MOGα1+10, MOGα1, MOG10, and MOG10MOG10 cell slides, and the results are shown in Table 2 below.
[0140] Table 2
[0141] MOGα1+10 MOGα1 MOG10 MOG10MOG10 Positive 30 29 28 28 Negative 0 1 2 2
[0142] Among them, one case was not detected only on MOGα1 slides, and two cases were not detected only on MOG10 and MOG10MOG10 slides, while all 30 cases were detected using MOGα1+10 cell slides. The experimental results show that compared with single-transfected MOGα1, MOG10 and MOG10MOG10, co-transfected MOGα1+10 has higher detection sensitivity and is less likely to miss positive detection when detecting unknown samples. The staining results are shown in Figure 2. Figure 5 shown.
[0143] Experimental conclusion 3
[0144] In the immunofluorescence cell experiment, some cells will have spherical nonspecific staining suspected of positive signals. From the experimental results of the above embodiments and comparative examples, it can be seen that 30 MOG-IgG positive samples were detected using MOGα1+10, MOGα1, MOG10, and MOG10MOG10 cell slides, and it was found that about 20% of the samples were detected by single-transfected MOGα1, MOG10, and MOG10MOG10 slides. The positive cell staining morphology was spherical, while the positive cell staining morphology on the co-transfected MOGα1+10 was slightly larger and spherical, which was easier to distinguish from the spherical nonspecific staining, reducing the risk of misjudgment by the tester. The staining results are as follows Figure 6 shown.
[0145] The above contents are only for explaining the technical idea of the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.
Claims
1. A detection material for MOG-IgG autoantibodies based on the CBA method, characterized in that: The detection material is a detection material capable of simultaneously overexpressing MOGα1 and MOG10; The detection material is obtained by co-transfecting a recombinant vector of the MOGα1 gene and a recombinant vector of the MOG10 gene into cells; the recombinant vector of the MOGα1 gene is PCDNA3.1-MOGα1 or 17T2A-MOGα1; the recombinant vector of the MOG10 gene is PCDNA3.1-MOG10 or 17T2A-MOG10; the cell is a HEK293T cell; the sequence number of the MOGα1 gene is NM_206809.4, and the sequence number of the MOG10 gene is NM_001363610.2; the mass ratio of the recombinant vector of the MOGα1 gene to the recombinant vector of the MOG10 gene is 1:1-3; The detection material is a cell slide.
2. The detection material for MOG-IgG autoantibodies based on the CBA method according to claim 1, characterized in that: The total mass of the recombinant vector of the MOGα1 gene and the recombinant vector of the MOG10 gene for co-transfection is 2-10 μg; during co-transfection, the mass ratio of the total mass of the recombinant vector to the mass of polyethyleneimine is ≤1.
3. Use of the detection material for MOG-IgG autoantibodies based on the CBA method according to any one of claims 1 to 2 in the preparation of a kit for detecting MOG-IgG autoantibodies.
4. A method for preparing a detection material for MOG-IgG autoantibodies based on the CBA method according to any one of claims 1 to 3, characterized in that: The following steps are involved: 1) The recombinant vector of the MOGα1 gene and the recombinant vector of the MOG10 gene were co-transfected into cells to obtain transfected cells that simultaneously overexpressed MOGα1 and MOG10; 2) Fix the transfected cells, wash them, and add antigen retrieval solution to terminate the treatment; 3) The cell slide obtained after the treatment in step 2) is washed and dried to obtain a detection material for MOG-IgG autoantibodies based on the CBA method.
5. The method for preparing a detection material for MOG-IgG autoantibodies based on the CBA method according to claim 4, characterized in that: The recombinant vector of the MOGα1 gene is PCDNA3.1-MOGα1 or 17T2A-MOGα1; the recombinant vector of the MOG10 gene is PCDNA3.1-MOG10 or 17T2A-MOG10; and the cell is HEK293T cell.
6. The method for preparing a detection material for MOG-IgG autoantibodies based on the CBA method according to claim 4, characterized in that: The total mass of the recombinant vector of the MOGα1 gene and the recombinant vector of the MOG10 gene for co-transfection is 2-10 μg; during co-transfection, the mass ratio of the total mass of the recombinant vector to the mass of polyethyleneimine is ≤1; the mass ratio of the recombinant vector of the MOGα1 gene to the recombinant vector of the MOG10 gene is 1:1-3.
